Vimarsana
Biggest News Aggregation in the World

Fraiser Kansteiner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fraiser Kansteiner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fraiser Kansteiner Today - Breaking & Trending Today

Chutes & Ladders—FDA nod for Biogen's Aduhelm sees trio of AdComm members hit the exit - Vimarsana News

Chutes & Ladders—FDA nod for Biogen's Aduhelm sees trio of AdComm members hit the exit

Ogilvy and McCann heavyweight Andrew Schirmer has joined Syneos Health's GSW New York as president. Three members of the FDA panel that argued against aducanumab have quit in the wake of the Alzheimer's drug's approval. Inogen, recently equipped with a new CEO, has tapped BD vet Stanislav Glezer, M.D., as its chief medical officer.

Chutes & Ladders—Another Novartis exec answers the biotech call, this time for gene therapy startup Tevard - Vimarsana News

Chutes & Ladders—Another Novartis exec answers the biotech call, this time for gene therapy startup Tevard

Novartis has lost another NIBR exec to the call of biotech. Blueprint Medicines has added another BMS vet to its roster. And Iovance quietly announced its CEO's departure Wednesday.

Chutes & Ladders—Gossamer vet Salter-Cid dons CSO mantle at Flagship's new Pioneering Medicines unit - Vimarsana News

Chutes & Ladders—Gossamer vet Salter-Cid dons CSO mantle at Flagship's new Pioneering Medicines unit

Former Bristol Myers Squibb compatriots are reuniting at Flagship Pioneering. Natural killer cell biotech Acepodia has enlisted AbbVie oncology exec Thorsten Graef as its chief medical officer. And Centessa has called upon a former AstraZeneca heavyweight as its new CMO.

Chutes & Ladders—3 weeks after leaving bluebird, CMO Davidson lands at Tessera - Vimarsana News

Chutes & Ladders—3 weeks after leaving bluebird, CMO Davidson lands at Tessera

Tyler Jacks, Ph.D., after 19 years. The director role will be taken over by Matthew Vander Heiden, M.D., Ph.D., a professor of biology at MIT and a medical oncologist at Dana-Farber Cancer Institute. He became a member of the Koch Institute in 2010 and took over for Jacks on Thursday, MIT said. Jacks will continue to lead the Bridge Project, which unites bioegnineers, cancer scientists and clinical oncologists from the Koch Institute and the Dana-Farber/Harvard Cancer Center. > Atara Biotherapeutics ushered Amie Krause into the role of senior vice president and chief people officer Apri...

Continuous Manufacturing of Liposomal Products - Vimarsana News

Continuous Manufacturing of Liposomal Products

Continuous Manufacturing of Liposomal Products DIANT Phar Image Credit: InProcess Continuous manufacturing is starting to gain increased interest over traditional batch processing for nanoparticle drug delivery systems. DIANT Pharma Inc. (DIANT) provides a turnkey solution for the continuous processing of nanoparticles by offering multiple modules and integrated process analytical technology as a single closed-system. Inventors of the Continuous Manufacturing System DIANT is a startup co-founded by Antonio Costa, Ph.D. and Diane Burgess, Ph.D.  In 2020, DIANT licensed their ...